VTRS vs VYNE · rev $7.27B vs rev $501.0K
Viatris Inc (VTRS) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
VTRS currently screens at market cap $10.83B. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the VTRS and VYNE stock pages for the full models.
Not investment advice.